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Axonal maturation and myelination are essential processes in establishing an 
efficient neuronal signaling network. Here, we show that nardilysin (N-arginine 
dibasic convertase: NRDc), a metalloendopeptidase enhancer of protein 
ectodomain shedding, is a critical regulator of these processes. NRDc–/– mice had 
smaller brains with a thin cerebral cortex, in which there were less myelinated 
fibers with thinner myelin sheaths and smaller axon diameters. NRDc–/– mice also 
showed hypomyelination in the peripheral nervous system (PNS). Neuron-specific 
overexpression of NRDc induced hypermyelination, indicating that the level of 
neuronal NRDc regulates myelin thickness. Consistent with these findings, NRDc–/– 
mice showed impaired motor activities and cognitive deficits. Further, NRDc 
enhanced ectodomain shedding of neuregulin1 (NRG1), which is a master 
regulator of myelination in the PNS. Based on these data, we propose that NRDc 
regulates axonal maturation and myelination in the CNS and PNS, in part, 
through the modulation of NRG1 shedding. 
 Myelination of axons by glial cells, such as oligodendrocytes in the CNS and 
Schwann cells in the PNS, is essential in rapid impulse conduction. Myelination is 
coordinated by the interaction between axons and glial cells. While the diameter of an 
axon dictates whether myelination is initiated, myelination may further induce radial 
growth of axons1,2. As axonal conduction is determined by axon caliber and myelin 
sheath thickness, axonal maturation (radial growth of axon) and myelination are 
essential processes for establishing an efficient neuronal signaling network3,4. Several 
lines of evidence suggest that bidirectional signaling between axon and myelin 
maintains neuronal functions. For instance, some oligodendrocyte-specific proteins, 
such as proteolipid protein and 2’,3’-cyclic nucleotide phosphodiesterase (CNP), are 
required to maintain axonal integrity5,6. On the other hand, neuregulin1 (NRG1), a 
member of the epidermal growth factor (EGF) family, induces axonal signaling and is 
required for glial differentiation, proliferation and myelination7-9. NRG1 is synthesized 
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as a transmembrane protein and then shed from the cell surface by proteolytic cleavage 
in the juxtamembrane region10. ADAM proteases and BACE1 (β-secretase) have been 
proposed as sheddases for NRG111-15. As BACE1-deficient mice show a 
hypomyelination phenotype13-15, shedding of NRG1 is thought to be important in 
myelination in vivo. However, the underlying mechanism by which NRG1 shedding is 
regulated is poorly understood. 
 NRDc is a zinc peptidase of the M16 family, which selectively cleaves dibasic 
sites16,17. We identified NRDc as a specific binding partner of HB-EGF, and 
demonstrated that NRDc enhances HB-EGF shedding through activation of tumor 
necrosis factor-α converting enzyme (TACE; ADAM17)18,19. We also showed that 
NRDc enhances the ectodomain shedding of multiple membrane proteins including 
amyloid precursor protein (APP) and tumor necrosis factor-α through activation of 
several ADAM proteases20,21. These results suggest that NRDc may regulate the 
ectodomain shedding of a wide range of membrane proteins. To explore the 
physiological functions of NRDc, we generated NRDc-deficient mice and found that 
these mice show impaired axonal maturation and hypomyelination in both the CNS and 
PNS. Further, we found that NRDc regulates axonal maturation and myelination in the 




Small brains in NRDc–/– mice 
NRDc is highly expressed in brain lysates of early postnatal mice, but at a lower level in 
those of adult mice (Fig. 1a; left panel). Immunohistochemical analysis showed that 
NRDc is expressed in neurons and dendrites, but not in glial cells (Fig. 1b and 
Supplementary Fig. 4a)20. These findings were supported by in situ hybridization, 
which showed little or no NRDc mRNA in the corpus callosum (Supplementary Fig. 
3).  
 To examine the physiological functions of NRDc, we generated mice deficient 
in NRDc by gene targeting (Supplementary Fig.1a). No NRDc mRNA or protein was 
detected by real-time PCR (data not shown) and Western-blot analysis, respectively, in 
the brain (Fig. 1a; center panel) and all other tissues tested from NRDc–/– mice (data not 
shown). Immunostaining of tissue sections also showed a lack of NRDc protein in the 
cerebral cortex of NRDc–/– mice (Supplementary Fig. 1c). Levels of NRDc protein in 
embryonic fibroblasts (MEF) isolated from NRDc+/+, NRDc+/–, or NRDc–/– mice 
correlated with the predicted gene dosage of NRDc in these mice (Fig. 1a; right panel). 
 Pups lacking NRDc were born at the expected Mendelian ratio. However, 
approximately 80% died within 48 hours after birth. NRDc–/– pups weighed 
approximately 30% less than NRDc+/+ and NRDc+/– littermates, indicating that NRDc is 
indispensable for normal prenatal growth. NRDc–/– mice that survived remained smaller 
than their wild-type and heterozygous littermates throughout postnatal development, 
and had average brain weights 29 % below those of NRDc+/+ mice at postnatal day 90 
(P90) (NRDc+/+; 521.0 ± 30.0 mg, NRDc–/–; 371.5 ± 16.8 mg, n = 5, p < 0.001) (Fig. 1c). 
While NRDc–/– mice that survived lived until two years of age, they showed several 
prominent neurological disorders. For example, NRDc–/– mice exhibited enhanced 
limb-clasping reflexes when suspended by the tail, whereas control mice extended their 
limbs (Fig. 1d).  
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 To assess the underlying neuropathology, brains of NRDc–/– mice were 
examined histologically. While the gross anatomy of NRDc–/– brain was normal at P1, 
P14 and P30 (Supplementary Fig. 2), a thin cerebral cortex and enlarged lateral 
ventricles were observed at P90 (Fig. 1e). Nissl staining of the NRDc–/– cortex 
demonstrated greater neuronal cell density than in the NRDc+/+ cortex (Fig. 1f,g). 
Furthermore, there were no differences in the number of TUNEL-positive cells detected 
in the cortex of NRDc+/+ and NRDc–/– mice (data not shown), indicating no excessive 
loss of neurons in the NRDc–/– cortex. 
 
Hypomyelination in the CNS of NRDc–/– mice 
We next examined the integrity of axons and myelin using silver impregnation and luxol 
fast blue (LFB) staining, respectively. In NRDc–/– brain, much less silver impregnation 
was detected, especially in the corpus callosum and cortical layers adjacent to it (Fig. 
2a,c). Similarly, LFB staining was markedly weaker in this region (Fig. 2b,d). These 
results suggested a decreased volume of axons and myelin in NRDc–/– brain, especially 
in the corpus callosum. Furthermore, levels of the axonal marker neurofilament-H 
(NF-H; Fig. 2e), and myelin markers, CNP and myelin basic protein (MBP) (Fig. 2f), 
were lower in the corpus callosum in NRDc–/– brain at P30. Western blotting also 
showed reduced CNP and MBP protein levels even at an earlier stage (P14) in NRDc–/– 
brain extracts (Fig. 2g), suggesting that NRDc–/– mice manifest a severe impairment of 
axonal maturation and hypomyelination starting at the early stages of these processes. 
Neuronal expression of NRDc was detected in whole regions of the brain, but there 
were some prominent regional differences. For example, NRDc was highly expressed in 
cortical neurons, but neurons in striatum expressed relatively low levels of NRDc 
(Supplementary Fig. 4a), similar to the expression pattern in human brain22. Consistent 
with these results, the myelination defect in NRDc–/– striatum was not as obvious as the 
defect in the cortex, hippocampus and corpus callosum (Supplementary Fig. 4b). 
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These results suggest a correlation between the expression level of NRDc and the extent 
of myelination defect in NRDc–/– mice.  
 On the other hand, Western blotting using the same set of brain extracts 
showed that the expression of platelet-derived growth factor receptor-α (PDGFR-α) and 
oligodendrocyte lineage gene 2 (olig2)23, markers of oligodendrocyte-precursors, and 
GST-π, a marker of mature oligodendrocyte, are not reduced in NRDc–/– (Fig. 2g), 
suggesting that oligodendroglial differentiation is normal in NRDc–/– mice. Moreover, 
quantitative analysis of olig2-positive cells at E18.5 and P5 demonstrated that there are 
no differences in the number of oligodendrocyte precursors between NRDc+/+ and 
NRDc–/– brains (Supplementary Fig. 5). These data suggest that NRDc affects 
myelination, but not differentiation of oligodendrocytes. 
 To obtain direct evidence of impaired axonal maturation and hypomyelination 
in the CNS, we analyzed sections of the corpus callosum in NRDc–/– mice and NRDc+/+ 
littermates between P14 and P365 by electron microscopy (Fig. 3a, and 
Supplementary Fig. 6a). The proportion of myelinated axons was dramatically reduced 
in NRDc–/– mice at all stages examined (Fig. 3c). At P14, only approximately one 
seventh of NRDc–/– axons were myelinated compared to NRDc+/+ axons, indicating a 
significant delay in the initiation of myelination in NRDc–/– mice. The proportion of 
myelinated axons in the NRDc–/– CNS was only 21.0 % at P90, and did not approach the 
level seen in NRDc+/+ mice even at P365 (Fig. 3c). We next compared myelin sheath 
thickness in the NRDc–/– and NRDc+/+ corpus callosum by determining the g-ratio24 
(axon diameter / total fiber diameter) of myelinated fibers at P30, P90, P120 and P365 
(Fig. 3b, and Supplementary Fig. 6b). Average g-ratios were significantly higher in 
NRDc–/– mice at all stages (Fig. 3d), indicating that myelin sheaths are thinner in 
NRDc–/– compared to those of NRDc+/+ mice. The average diameters of myelinated 
axons were also significantly smaller in NRDc–/– mice than wild-type littermates (Fig. 
3e). Although axons were hypomyelinated, the ultrastructure of myelin sheaths of 
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NRDc–/– mice appeared normal and indistinguishable from those of NRDc+/+ mice (data 
not shown). Together, these data indicate that NRDc–/– mice have fewer myelinated 
fibers in the corpus callosum, and the fibers have thinner myelin sheaths and smaller 
axon diameters. As NRDc is highly expressed in neurons, but not expressed or 
expressed at very low levels in glial cells (Fig. 1b, Supplementary Fig. 4a)20, we 
propose that the loss of NRDc in neurons may cause an impairment of axonal 
maturation, resulting in perturbation of axonal signaling required for oligodendrocytes 
to properly myelinate axons and hypomyelination.  
 
Hypomyelination in the PNS of NRDc–/– mice 
NRDc is also expressed in spinal neurons and dorsal root ganglion neurons 
(Supplementary Fig. 3b). To investigate the role of NRDc in axonal maturation and 
myelination in the PNS, we analyzed sciatic nerves of NRDc–/– mice by electron 
microscopy and found that sciatic nerve of NRDc–/– mice is hypomyelinated (Fig. 4a). 
Quantitative analysis by measuring the g-ratio of myelinated fibers demonstrated that 
the myelin sheath thickness is thinner in NRDc–/– mice at both P30 and P365. The 
diameter of myelinated axons was also significantly smaller in NRDc–/– nerve compared 
with NRDc+/+ nerve (Fig. 4b,c).  
 We also examined the morphology of Remak bundles (Fig. 4d,e,f). Remak 
bundles in NRDc–/– nerves contained approximately two times more axons than 
NRDc+/+ nerves at P30 and P365 (Fig. 4d,e). In addition, there were many unsegregated 
or poorly-segregated axons which lacked intervening Schwan cell processes in NRDc–/– 
bundles (Fig. 4d,f). These findings indicate that NRDc is critical in axonal maturation 
and myelination of both the CNS and PNS. Interestingly, the observed hypomyelination 
and morphological change of Remak bundles in the PNS of NRDc–/– mice were very 
similar to those described in NRG1 typeIII +/– and BACE1–/– mice7,8,13,14,25.  
 
 8 
Level of neuronal NRDc regulates myelin thickness 
To determine the dose-dependent effects of NRDc expression on the CNS phenotypes, 
we examined brains from NRDc+/– mice. The gross anatomy of NRDc+/– brains showed 
no cortical shrinkage, but did show significantly enlarged lateral ventricles (Fig. 5a). 
While no obvious differences between NRDc+/+ and NRDc+/– brains were detected by 
LFB staining (Fig. 5a,b), immunostaining showed decreased expression of the myelin 
and axon markers, MBP and NF-H, in NRDc+/– corpus callosum (Fig. 5d,e). These 
findings were confirmed by Western blotting using whole brain lysates (Fig. 5f). Further, 
we analyzed NRDc+/– corpus callosum by electron microscopy and found that the 
myelin sheath thickness of NRDc+/– mice is significantly thinner than that of NRDc+/+ 
mice (Average g-ratio, NRDc+/+; 0.725 ± 0.020 s.e.m., NRDc+/–; 0.761 ± 0.001 s.e.m., n 
> 1000 fibers from each group, P < 0.0001; Fig. 5g,h). Axon diameters of NRDc+/– mice 
were also smaller compared to those of NRDc+/+ mice (NRDc+/+; 0.650 ± 0.018 µm, 
NRDc+/–; 0.582 ± 0.006 µm, P < 0.0001). Thus, NRDc+/– mice show an intermediate 
CNS phenotype between NRDc+/+ and NRDc–/– mice, indicating that the level of NRDc 
expression in neurons affects axonal maturation and myelination.  
 The loss-of-function approach using NRDc–/– mice revealed that NRDc is 
essential for axonal maturation and myelination in the CNS. To further define the role of 
NRDc in these processes, a gain-of-function approach using transgenic mice that 
overexpress mouse NRDc under the control of the CamKII promoter (NRDc-Tg) was 
undertaken26,27. Western blot analysis of whole brain extract of NRDc-Tg mice at P90 
showed increased NRDc expression (Fig. 6a). The CamKII promoter is specifically 
activated in neurons of cerebral cortex and hippocampus26,27, where the increased 
expression of NRDc was confirmed by immunostaining (Fig. 6b,c). To see the regional 
effect of NRDc overexpression, we divided mouse brains into two regions: cerebral 
cortex plus hippocampus (frontal region) and brain stem plus cerebellum (posterior 
region). Western immunoblotting showed increased expression of NRDc protein only in 
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the frontal region (Fig. 6d). The expression of myelin markers, MBP and CNP, was also 
increased in the frontal region, but not in the posterior region (Fig. 6d). Higher 
expression of MBP in corpus callosum was also detected by immunostaining (Fig. 6e). 
Importantly, analysis of myelination in the NRDc-Tg corpus callosum by electron 
microscopy demonstrated that the average g-ratio was significantly lower, indicating 
that the myelin sheaths are thicker in NRDc-Tg mice (Fig. 6g,h). On the other hand, 
there was no significant difference in the diameter of myelinated axons in the corpus 
callosum between the NRDc-Tg and wild-type mice (average diameter, wild-type; 0.80 
± 0.39 µm, NRDc-Tg; 0.81 ± 0.39 µm, n.s). These results provide further evidence that 
the level of neuronal NRDc regulates myelin sheath thickness. The CamKII promoter is 
activated around P5, which is after the differentiation of neuronal cells and prior to 
subcortical myelination27. Thus, NRDc most likely affects myelination through 
regulating axonal signals transmitted from differentiated neurons. 
 
Impaired motor activity and cognitive deficits in NRDc–/– mice 
To examine the effect of NRDc on neurological functions, NRDc–/– mice were analyzed 
with a battery of behavioral tests28. Neuromuscular strength was examined with grip 
strength and wire-hanging tests. While NRDc–/– mice showed reduced grip strength (Fig. 
7a), no significant difference between NRDc+/+ and NRDc–/– mice was detected in the 
wire-hanging test (Supplementary Fig. 7a), indicating that NRDc–/– mice possess 
sufficient grip strength to hold their body weight. We next assessed motor coordination 
and balance with the beam test and rotarod test29. In the beam test, NRDc–/– mice moved 
much slower and slipped more frequently than NRDc+/+ mice (Fig. 7b,c). NRDc–/– mice 
also had a significantly shorter latency to fall in the rotarod test (Fig. 7d). These results 
indicate that there is a severe impairment of motor coordination and balance in the 
NRDc–/– mice.  
 In contrast to motor activity, sensory pathways are apparently conserved in 
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NRDc–/– mice because their reactions were similar to those of NRDc+/+ mice in the hot 
plate test (Supplementary Fig. 7b). Cognitive functions of NRDc–/– mice were 
examined with the T-maze test, in which working memory and reference memory were 
evaluated by a forced alternation task and a left-right discrimination task, respectively30. 
In both tasks, NRDc–/– mice took much longer to complete a session, most likely due to 
impaired motor activity (Supplementary Fig. 7c and data not shown). While the 
percentage of correct choices in the forced alternation task was significantly lower in 
NRDc–/– mice, there were no significant differences in the left-right discrimination task 
between NRDc+/+ and NRDc–/– mice (Fig. 7e,f). Together, these results demonstrate that 
the reference memory is preserved, whereas the working memory is impaired in 
NRDc–/– mice. While these behavioral alterations are consistent with the axonal and 
myelination defects, spinal or cerebellar defects might also influence the overall 
performance of NRDc–/– mice. 
 
NRDc regulates NRG1 shedding through BACE1 and TACE 
NRG1, one of the master regulators of myelination, is synthesized as a transmembrane 
protein and then proteolytically shed from the cell surface8,10. Recent reports of 
hypomyelination in BACE1-deficient mice have implicated BACE1 in NRG1 
shedding13-15. NRG1 is also shed from the cell surface by TACE11, although there are no 
information about nervous system phenotypes of TACE-deficient mice due to its early 
lethality. These findings, along with the potentiating effect of NRDc on protein 
ectodomain shedding19-21, prompted us to examine whether NRDc affects axonal 
maturation and myelination through regulating NRG1 shedding by BACE1 or TACE. 
To determine whether NRDc potentiates BACE1/TACE activity, we performed 
co-transfection experiments in COS7 cells. NRG1 type I was tagged with HA at the 
N-terminus, so that the full length and N-terminal fragment (NTF) of NRG1 type I 
could be detected with an anti-HA antibody. Co-expression of NRDc and BACE1 
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increased NTF levels in total cell lysates, but not in the conditioned medium (Fig. 8a,b). 
In contrast, co-expression of NRDc with TACE clearly increased NTF levels in the 
conditioned medium (Fig. 8a,b). These results suggest that NRDc potentiates 
TACE-mediated NRG1 cleavage at the cell surface, whereas NRDc enhances BACE1 
cleavage of NRG1 in intracellular compartments. As the enhancement of 
BACE1-mediated cleavage of NRG1 was not associated with an increase in NTF levels 
in the conditioned medium, NRDc is thought to potentiate BACE1 in endocytic 
pathways and direct the cleaved NRG1 to degradation31. Similar to the direct interaction 
of NRDc and TACE19, co-precipitaion demonstrated that NRDc forms as trimolecular 
complex with BACE1 and NRG1, suggesting that these proteins physically and 
functionally interact (Fig. 8c).  
 Given these findings, we examined the expression pattern of endogenous 
NRG1 protein in fibroblasts derived from NRDc–/– and NRDc+/+ mice. Western blot 
analysis using the antibody against the C-terminus of NRG1 (NRG-C), which 
recognizes both full length NRG1 and C-terminal fragment of NRG1 (CTF), showed an 
increase in full length NRG1 and decrease in CTF in NRDc–/– cells compared to 
NRDc+/+ cells (Fig. 8d; left). In addition, while an antibody against the intracellular 
N-terminus of NRG1 type III detected the cleaved NTF of NRG1 type III in NRDc+/+ 
cells, it barely detected the cleaved fragment in NRDc–/– cells (Fig. 8d; right). These 
results indicate that NRDc positively regulates the proteolytic cleavage of both type I 
and type III NRG1.  
 Next, we examined the expression of NRG1 in brain extracts from NRDc+/+ 
and NRDc–/– mice at P14. Western blotting with antibodies against the C-terminus of 
NRG1 type I and N-terminus of NRG1 type III showed a similar pattern as found in 
MEF cells (Fig. 8e), although the difference between the two genotypes was less 
evident in the brain extract. These results are consistent with the fact that the proteolytic 
cleavage of NRG1 type I and type III in brain is regulated by NRDc. We then analyzed 
 12 
the protein expression of BACE1. Intriguingly, mature BACE1 in NRDc–/– brain was a 
little smaller than that of NRDc+/+ brain (Fig. 8e). In addition, the ratio of the mature 
form to immature form of BACE1 was clearly higher in NRDc+/+ brains compared with 
NRDc–/– brains (NRDc+/+; 2.21 ± 0.62, NRDc–/–; 0.75 ± 0.08, n = 3, P = 0.04), indicating 
that the protein maturation of BACE1 is impaired in NRDc–/– brains. These results 
suggest that NRDc regulates BACE1-mediated NRG1 shedding through affecting 
BACE1 maturation and BACE1 sheddase activity. On the other hand, the mRNA levels 
of NRG1 and BACE1 were not significantly different between NRDc+/+ and NRDc–/– 
brains (Supplementary Fig. 8), further indicating that NRDc post-translationally 
modulates the expression and activity of NRG1 and BACE1. 
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DISCUSSION 
Our findings provide the first in vivo evidence that NRDc is a critical regulator of 
axonal maturation and myelination in the CNS and PNS. In the CNS, axon diameter and 
myelin thickness correlated with levels of NRDc expression (homozygous < 
heterozygous < wild-type mice). Our results suggested that NRDc affects myelination 
through regulating axonal maturation because myelin thickness was proportional to the 
diameter of axons1,2. Neuron-specific overexpression of NRDc, however, did not affect 
the axon caliber, but instead induced hypermyelination, providing additional evidence 
that NRDc is a critical regulator of myelination. Importantly, because we did not see 
any differences in the number of oligodendrocyte precursor cells and the expression 
level of specific oligodendrocyte precursor markers between NRDc+/+ and NRDc–/– 
mice, NRDc appears to specifically regulate myelination, and not oligodendrocyte 
differentiation nor proliferation. In addition, as expression of NRDc is confined to 
neurons, the effect of NRDc on oligodendrocyte is non-cell autonomous. Instead, our 
data suggest that NRDc affects axonal signaling between neurons and oligodendrocytes. 
 NRG1 is the best characterized neuronal factor that induces axonal signaling 
required for the entire program of glial differentiation, proliferation and 
myelination8,10,32. NRG1, a member of EGF family, is synthesized as a transmembrane 
protein that is proteolytically cleaved in the juxtamembrane region. ADAM proteases 
(TACE / ADAM1711 and ADAM1912,33) and BACE113,14 have been proposed to cleave 
NRG1. Further, BACE1-deficient mice exhibit hypomyelination13-15 and 
ADAM19-deficient mice show delayed remyelination after injury33, suggesting that 
proteolytic cleavage of NRG1 is important for myelination. Our data indicate that 
NRDc is a critical regulator of NRG1 cleavage in vivo. First, gain of function 
experiments in cells showed that NRDc enhances BACE1- and TACE-mediated NRG1 
cleavage. Second, loss of function experiments in cells showed an increase of the 
full-length NRG1 and a decrease of cleaved NRG1, indicating that NRG1 cleavage is 
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reduced in the absence of NRDc. Further, similar to the results from NRDc–/– cells, brain 
lysates of NRDc–/– mice showed a significant decrease in levels of cleaved NRG1. 
NRDc–/– mice also showed hypomyelination not only in the CNS, but also in the PNS, 
where NRG1 is a master regulator of myelination. Lastly, we showed that NRDc forms 
a complex with BACE1 and NRG1, suggesting that these molecules interact 
functionally. The present study, therefore, suggest that regulation of NRG1 proteolysis 
by NRDc is a critical post-translational modification for myelination. 
 Although several studies have suggested the involvement of NRG1 in 
oligodendrocyte differentiation and CNS myelination25,32,34, the role of NRG1 in CNS 
myelination is still controversial due to the embryonic lethality of NRG1 deficient mice. 
However, a recent study showed normal myelination in a series of conditional null 
mutants of NRG1 that lack the gene at different stages during CNS development, 
suggesting that NRG1 may function differently in the PNS and CNS35. Because our data 
indicated that NRDc regulates myelination in both the CNS and PNS, NRDc may affect 
different proteins in the CNS. On the other hand, while both NRDc–/– and BACE1–/– 
mice showed hypomyelination in the CNS and PNS, no abnormalities in axon diameter 
and initiation of myelination have been reported in BACE1–/– mice13-15. Taken together, 
the effect of NRDc in the CNS cannot be attributed merely to NRG1 or BACE1. We 
have previously shown that NRDc potentiates several ADAM proteases19-21 and show 
here that NRDc also enhances the capacity of BACE1 to process NRG1. The enhancing 
effect of NRDc on ADAM proteases is not substrate-specific because NRDc can 
potentiate TACE-mediated shedding of HB-EGF, TNF-α, APP and NRG119-21. This 
might also be the case for BACE1 because our studies showed that NRDc affects the 
maturation of BACE1 (Fig. 8). 
Axonal maturation and myelination are essential in nerve conduction and 
aberrant in various neuropathologies. For example, the primary pathologic event of 
multiple sclerosis is demyelination, and remyelination correlates with recovery from 
 15 
clinical symptoms36. Given the dose-dependent effect of NRDc on myelin thickness, 
NRDc could be a potential pharmacological target of this most common neurological 
disorder of young adults. NRDc could also play an important role in the regeneration of 
injured axons. In fact, the critical regulatory functions of NRDc in 
axon-oligodendrocyte signaling, axon maturation and myelination suggest that NRDc 
may impinge on a broad range of neurological disorders. 
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Figure Legends 
Figure 1 Expression of NRDc in brains and gross CNS phenotypes of NRDc–/– mice. 
(a) Immunoblot analysis of brain extracts (left, center) or total cell extracts (right) 
stained with antibodies to NRDc and GAPDH. Analysis of brain extracts from 
wild-type mice at 5, 14, 90, and 365 postnatal days (P5, P14, P90 and P365; left); and 
from control wild-type (+/+) and NRDc–/– mice (–/–) at P90 (center). Analysis of the 
total extracts of MEF isolated from NRDc+/+, NRDc+/–, or NRDc–/– mice (right). Full 
-length blots are presented in Supplementary Figure 9. (b) Immunohistochemistry 
using an anti-NRDc antibody (green) with cerebral cortex sections from wild-type mice 
at P30. The section was double-stained with fluorescent Nissl (red). Scale bars, 250 µm. 
(c) Brains of NRDc–/– mice (right) and control wild-type littermates (left) at P90. (d) 
Enhanced limb-clasping reflex of NRDc–/– (right) compared with wild-type (left) mice 
at P42. (e) H&E-stained sections of the brain hemisphere of NRDc–/– mice (right) and 
wild-type littermates (left) at P90. An enlargement of the lateral ventricles and cortical 
shrinkage in NRDc–/– brain is shown. (f,g) Nissl-stained sections of cerebral cortex of 
NRDc–/– mice (right) and wild-type littermates (left) at P90 (Scale bars, 500 µm). 
Counting of Nissl-positive neurons at the same bregma levels (6 non-overlapping fields 
/ n = 2 per genotype, results are mean ± s.e.m. *p < 0.01) showed greater neuronal cell 
density in the NRDc–/– cortex. 
 
Figure 2 Impaired axonal maturation and hypomyelination in the CNS of NRDc–/– mice. 
(a-d) Silver impregnation by Bielschowskey method (a,c) and LFB staining (b,d) of 
NRDc–/– brain (–/–; right) and wild-type brain (+/+; left) at P90, showing impairment of 
axonal maturation and hypomyelination in NRDc–/– brain (a,b; Scale bars, 2 mm), 
especially in the corpus callosum (c,d; Scale bars, 500 µm). (e,f) Immunohistochemistry 
using anti-NF-H antibody (e), anti-CNP antibody and anti-MBP antibody (f) of corpus 
callosum from control wild-type mice (+/+; left) and NRDc–/– mice (–/–; right) at P30. 
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Scale bars, e; 250 µm, f; 500 µm. (g) Immunoblot analysis of brain extracts from 
wild-type and NRDc–/– brains at P14 showed a reduction of MBP, CNP and NF-H 
expression in NRDc–/– brains. On the other hand, there were no differences in Olig2, 
PDGFR-α, and GST-π, marker proteins of oligodendrocyte precursor or mature 
oligodendrocyte (n = 3 in each genotype). Full-length blots are presented in 
Supplementary Figure 9. 
 
Figure 3 Delay in the initiation of myelination and hypomyelination in NRDc–/– mice. 
Electron microscopic analysis of corpus callosum. (a) Electron micrographs of 
transverse sections at the corpus callosum from NRDc–/– mice (right) and wild-type 
littermates (left) at P14 (upper) and P90 (bottom). Scale bars, 2 µm. (b,d) Quantitation 
of myelin sheath thickness in the corpus callosum by analyzing g-ratios with electron 
micrographs. Scatter plots of myelin thickness, expressed as g-ratios, against axon 
diameters at P90 and P365 in NRDc–/– (black) and wild-type (red) corpus callosum (b). 
Average myelin sheath thickness (g-ratio) of myelinated fibers at P30, P90, P120 and 
P365, showing quantitative evidence of hypomyelination in the corpus callosum of 
NRDc–/– mice (d). Data represent the mean ± s.e.m. for 300 to 900 myelinated fibers 
from each group. *, p < 0.03, **, p < 0.0001. (c) Percentage of myelinated axons in the 
corpus callosum of NRDc–/– (black bars) and wild-type littermates (white bars) at P14, 
P30, P90, and P365. (e) Average diameters of myelinated axons in the corpus callosum 
at P30 and P365. Data represent the mean ± s.e.m. for 300 to 900 myelinated fibers 
from each group. *, p < 0.0003, **, p < 0.0001. 
 
Figure 4 Impaired axonal maturation and hypomyelination in the PNS of NRDc–/– mice.  
(a) Electron micrographs of sciatic nerves of NRDc+/+ (left) and NRDc–/– (right) mice at 
P365 showed obvious hypomyelination in NRDc–/– nerve. Scale bars; 2 µm. (b) Scatter 
plots of g-ratios and axon diameters at P30 and P365 of NRDc–/– (black) and wild-type 
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(red) sciatic nerves. (c) G-ratios and axon diameters at P30 and P365 of NRDc+/+ and 
NRDc–/– sciatic nerves. Data represent the mean ± s.e.m. for 750 myelinated fibers from 
each group (n = 4, for each genotype). *; p < 0.03, **; p < 0.01. (d) Electron 
micrographs of Remak bundles in sciatic nerves show altered axonal segregation in 
NRDc–/– bundles. Arrows indicate Schwann cell cytoplasmic processes between 
different axons. Note that many axons of NRDc–/– bundles are directly apposed without 
the cytoplasmic processes (arrowhead). Scale bars; 500 nm. (e) Average numbers of 
axons in a Remak bundle at P30 and P365 were significantly reduced in NRDc–/– sciatic 
nerves. Data represent the mean ± s.e.m. for 150 to 300 Remak bundle from each group 
(n = 2 for each genotype). ***; p < 0.0001. (f) Ratios of segregated axons in NRDc–/– 
sciatic nerves at P30 and P365 were reduced (150 to 300 Remak bundle from each 
group, n = 2 for each genotype).  
 
Figure 5 Intermediate CNS phenotype in heterozygous mutant of NRDc-deficient mice.  
(a,b) LFB staining of NRDc+/– brains (right) showed enlarged lateral ventricles 
especially in the frontal section (a), compared with wild-type brains (left), but no 
obvious cortical shrinkage. Scale bars, 1 mm. (c) Immunohistochemistry of NRDc+/– 
cortex (+/–; bottom) with anti-NRDc antibody showed the obvious reduction of NRDc 
expression. (d,e) Immunohistochemistry of NRDc+/+ (left) and NRDc+/– (right) corpus 
callosum at P90 using anti-MBP (d) and NF-H (e) antibody showed the decreased 
expression of the axonal and myelin markers in NRDc+/– brain. The sections were 
double-stained with fluorescent Nissl. Scale bars, c,d,e; 500 µm. (f) Immunoblot 
analysis of whole brain extracts using anti-NRDc, NF-H, MBP antibodies revealed the 
reduced expression of those proteins in NRDc+/– brains compared with their wild-type 
littermates. Full-length blots are presented in Supplementary Figure 9. (g) Electron 
micrographs of NRDc+/+ (left) and NRDc+/– (right) corpus callosum at P120. Scale bars, 
2 µm. (h) Scatter plots of g-ratio against axon diameters of NRDc+/+ (red) and NRDc+/– 
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(black) corpus callosum at P120.  
  
Figure 6 Transgenic overexpression of neuronal NRDc induces hypermyelination in the 
CNS. (a) Immunoblot analysis of total brain extracts from wild-type littermates (Wt) 
and CamKII-NRDc mice (NRDc-Tg) at P90 with anti-NRDc antibody. (b,c) 
Immunohistochemistry of sections from NRDc-Tg brains (right) using anti-NRDc 
antibody showed neuronal overexpression of NRDc in the cortex (b) and hippocampus 
(c) compared with Wt brains (left). Scale bars, 250 µm. (d) Brains of Wt and NRDc-Tg 
mice were divided into two regions at the border of cerebral cortex and cerebellum. 
Total brain extracts from frontal region (left panel) and posterior region (right panel) 
were analyzed by immunoblotting using anti-NRDc, CNP, MBP and NF-H antibody. 
Note that the increased expression of NRDc, CNP and MBP were detected only in the 
frontal region. Full-length blots are presented in Supplementary Figure 9. (e) 
Expression of myelin marker, MBP in the corpus callosum was increased in NRDc-Tg 
(right) compared with Wt (left). Scale bars, 500 µm. (f) Electron micrographs of corpus 
callosum from NRDc-Tg (right) and Wt (left) mice at P30. Scale bars, 500 nm. (g,h) 
Myelin sheaths are thicker in NRDc-Tg mice compared with Wt. Scatter plots of 
g-ratios against axon diameters at P30 in NRDc-Tg (black) and wild-type (red) corpus 
callosum (g) and average g-ratio (h) are shown. Data represent the mean ± s.e.m. for no 
fewer than 1000 myelinated fibers from each group (n = 4, for each genotype). 
 
Figure 7 Impaired motor activity and cognitive deficits in NRDc–/– mice. Mice at the 
age of 90 to 180 days were analyzed with a battery of behavioral tests (Age-matched 
littermates, n = 12; NRDc+/+, n = 6; NRDc–/–). (a) Grip strength test, showing the 
reduced forelimb grip strength of NRDc–/– mice. (b,c) The ability of mice to traverse a 
narrow beam to reach a dark box was analyzed in a beam test. NRDc–/– mice moved 
slower (b) and slipped more frequently (c) than NRDc+/+ mice. (d) Latency to fall from 
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a rotating drum was measured in a rotarod test. NRDc–/– mice showed a shorter latency. 
(e) The percentage of correct choices in the T-maze forced alteration task, showing 
impaired working memory in NRDc–/– mice. (f) The percentage of correct choices in the 
T-maze left-right discrimination task, showing no difference between NRDc+/+ and 
NRDc–/– mice. The genotype effect was analyzed by a two-way repeated ANOVA in all 
tests. 
 
Figure 8 NRDc regulates NRG1 shedding through BACE1 and TACE. (a) 
FLAG-tagged NRDc, V5-tagged BACE1, TACE, and HA-tagged NRG1-type1 were 
co-expressed in COS7 cells. Immunoblot analyses with the indicated antibodies were 
performed. Note that the cleaved N-terminal fragment (NTF) of NRG1 in the total cell 
lysates (TCL) is increased by the addition of NRDc to BACE1 (lane 3 and 4), while 
co-expression of NRDc with TACE clearly increased the NTF in the conditioned 
medium (CM) (lane 5 and 6). (b) Quantification of the cleaved NTF in the TCL and CM 
by densitometry. The ratio was arbitrarily set at 1 in control vector-transfected cells. 
Data represent the mean ± s.e.m. in five independent experiments. *, p < 0.05. (c) 
Immunoprecipitation of the co-transfected cell lysate with an anti-FLAG antibody 
showed a complex of NRDc, BACE1 and NRG1. Only the full-length (FL) of NRG1 is 
shown here. (d) Expression of endogenous NRG1-typeI and NRG1-typeIII in MEF cells 
isolated from NRDc+/+ or NRDc–/– mice. Note that the full-length (FL) of NRG1-typeI is 
increased and the cleaved C-terminal fragment (CTF) is decreased in NRDc–/– cells 
(lane2), and that the cleaved NTF of NRG1-typeIII is decreased in NRDc–/– cells (lane4). 
(e) Immunoblot analysis of brain extracts from control wild-type (+/+) and NRDc–/– 
(–/–) mice at P14 (n = 3 in each genotype) with indicated antibodies. Note that the 
full-length (FL) of NRG1 (~140 kD) is increased, while NTF of NRG1-typeIII (75 kD) 
is decreased in NRDc–/– brains. The mature form of BACE1 in NRDc+/+ brain extracts is 
indicated by an arrow. The ratio of the mature form to immature form is higher in 
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Generation of mutant mice 
NRDc-deficient mice (Acc.No. CDB0466K: 
http://www.cdb.riken.jp/arg/mutant%20mice%20list.html) were generated by gene 
targeting in TT237 embryonic stem (ES) cells as described at 
http://www.cdb.riken.jp/arg/protocol.html. The targeting vector was designed to replace 
exon 1 (Supplementary Figure 1a) with 
DT-A/lox71/LacZ-pA/frt/PGK-Neo/frt/loxP/pA cassette 
(http://www.cdb.riken.jp/arg/cassette.html), and successful homologous recombination 
in TT2-ES cells was confirmed by PCR (Forward primer (#1 in Supplementary Figure 
1a): 5’- CCTCAGCTCAGCCACTAGCCCTTG -3’, Reverse primer (#2): 5’- 
TCCAACCCGGCCTCGCTCACACCGA-3’) and Southern blotting in 2 clones, which 
yielded highly chimeric mice, respectively. We intercrossed the heterozygous offspring 
(F1) to obtain homozygous mutants (F2), which were genotyped with tail DNA by PCR 
using a mixture of three primers. Forward primer (#3 in Supplementary Figure 1a): 
5’- GGATGTCCAGCGCTACGACT-3’, Forward primer (#4): 5’- 
ATCGATGATATCAGATCCCC-3’, Reverse primer (#5): 5’- 
CCTCCCCTTTACCATCCATC-3’. Primers #3 and #5 amplify the wild-type allele (674 
bp) and primers #4 and #5 amplify the mutated allele (380 bp) (Supplementary Figure 
1b). Two strains of NRDc-deficient mice, derived from two different clones of ES cells, 
showed identical phenotypes. All analysis of homozygous mutant mice were done using 
F2 generation, which has 75 % of C57BL/6 and 25 % of CBA background. For the 
analysis of heterozygous mutant mice, F2 mice were backcrossed with C57BL/6 more 
than 6 times to exclude the possible effect of genetic heterogeneity on the phenotype of 
the heterozygous mice. 
 For the generation of neuron-specific NRDc-overexpressing transgenic mice, 
PCR-amplified cDNA encoding mouse NRDc was cloned downstream of the CamKIIα 
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promotor26. The construct was excised at a unique PacI site for DNA microinjection of 
fertilized mouse oocytes. Routine genotyping of tail DNA was conducted by PCR using 
the following primers. Forward primer: 5’-CCATAGCAACTGCCTCTTTG-3’, Reverse 
primer: 5’- GATCGCTGGGAGACTTGATG-3’.  
 Mice were housed in environmentally controlled rooms of the Institute of 
Laboratory Animals, Graduate School of Medicine, Kyoto University, under the 
Institute’s guidelines for animal and recombinant DNA experiments. 
 
Cells, plasmids and transfections 
Mouse embryonic fibroblasts (MEF) were isolated from either NRDc+/+, NRDc+/– or 
NRDc–/– embryos at embryonic day 14.5 (E14.5), and maintained in Dulbecco's 
modified Eagle's medium (DMEM) containing 5 % fetal bovine serum, 100 U/ml of 
penicillin, 100 mg/ml of streptomycin, and 2 mM l-glutamine. MEF were passed 
according to the 3T3 protocol and immortalized38. COS7 cells were cultured in DMEM 
containing 10 % fetal bovine serum, 100 U/ml of penicillin, 100 mg/ml of streptomycin, 
and 2 mM l-glutamine. Expression plasmid for human NRDc (pcDNA3-hNRDc-FLAG) 
was described previously19. Expression plasmids for V5-tagged human BACE1 and 
HA-tagged human NRG1-type I were generous gifts from A. Kinoshita and A. Sehara, 
respectively. The transfection of plasmids into COS7 cells was carried out using 
FuGENE6 (Roche) according to the manufacturer’s instructions. 
 
Immunoblot analysis and immunoprecipitation 
The preparation of total cell extract, immunoblotting and immunoprecipitation were 
performed as described previously19. For the preparation of brain extract, whole brain 
was homogenized by sonication in lysis buffer containing 10 mM Tris-HCl (pH 7.4), 
150 mM NaCl, 1% NP-40 and protease inhibitor cocktail (Complete Mini, Roche 
Diagnostics), followed by ultra-centrifugation at 100,000 g for 20 min at 4 ℃.  
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Primary antibodies used for the immunoblot analysis and immunoprecipitation were as 
follows; mouse monoclonal antibody for NRDc (#23)19, anti-glyceraldehyde-3 
phosphate dehydrogenase (GAPDH) (Research Diagnostics), anti-neuregulin (NRG-C) 
(Santa Cruz) for detection of the full-length and the cleaved C-terminus of neuregulin 
typeI and III, anti-neuregulin typeIII (Chemicon / Millipore) for detection of the 
full-length and the cleaved N-terminus of neuregulin typeIII, anti-BACE1 (EE-17) 
(Sigma), anti-PDGFR-α (Santa Cruz), anti-Olig2 (IBL, Japan), anti-GSTπ (Stressgen), 
anti-MBP (MBL, Japan), anti-CNP (Chemicon), anti-NF-H (Sigma), anti-HA (HA11) 
(Covance), anti-FLAG M2 (Sigma), and anti-V5 (Invitrogen). 
 
Histological procedures and immunohistochemistry 
Mice were anesthetized and transcardially perfused with 4 % paraformaldehyde (PFA) 
in PBS. Tissues were post-fixed in 4 % PFA for 16 hr and embedded in paraffin in the 
traditional way, and sectioned at 6 µm thickness on a microtome (Leica, RM2125RT). 
Standard histological methods including hematoxylin and eosin (H&E) staining, 
Klüver-Barrera staining and silver impregnation by the modified Bielschowsky method 
were performed with deparaffinized sections. For immunohistochemical staining, 
primary antibodies were used at the following dilutions after antigen retrieval; rabbit 
polyclonal antibody against NRDc, which was raised in our laboratory39, at 8 µg/ml; 
mouse anti-neurofilament-H (NF-H) (Sigma) at 1:200; mouse anti-2’, 3’-cyclic 
nucleotide 3’-phosphodiesterase (CNP) (Chemicon) at 1:200; rat anti- MBP at 1:500, 
and rabbit anti-Olig2 (IBL) at 1:200. After the incubation with primary antibodies, the 
sections were washed in PBS and incubated with the secondary antibody, i.e. Alexa 
Fluor 488 or 594 goat anti-mouse or anti-rabbit IgG (Invitrogen) at 1:200 for 1 hr, 
followed by counterstaining with the fluorescent Nissl staining, Neuro Trace 
(Invitrogen). The stained sections were examined under the fluorescence microscope, 




Electron Microscopy and Morphometry 
Mice were anesthetized and fixed via transcardial perfusion with 4 % PFA and 2 % 
glutaraldehyde in 0.1 M phosphate buffer. A block of approximately one×one×two mm3 
was removed from the body of corpus callosum at the level of the dorsal hippocampus 
and from the sciatic nerve, incubated for 2 hr at 4 °C in the same fixative, and 
contrasted with 1 % osmic acid in PBS. Tissues were dehydrated in an ethanol 
gradient from 50 % to 100 % and embedded in Epon. Semi-thin sections (0.9 µm) were 
stained with toluidine blue for survey by light microscopy. Ultra-thin sections (80 nm) 
were cut and stained with 2 % uranyl acetate (Watson’s modified method) and Reynolds 
lead citrate, and analyzed with a HITACHI H-7650 transmission electron microscope. 
Non-overlapping digitalized images of fiber cross-sections were obtained and analyzed 
using Image Pro Plus 3.0 software (Media Cybernetics Inc.). The g-ratio was 
determined by dividing the diameter of an axon (without myelin) by that of the total 
fiber diameter (axon + myelin sheath) from 300 to 1000 fibers in the corpus callosum 
(at least 6 animals per genotype). 
 
Behavioral analysis.  
Age-matched littermates of NRDc+/+ (n = 12) and NRDc–/– (n = 6) mice (P90 to P180) 
were analyzed with a comprehensive behavioral test battery including grip strength test, 
wire-hanging test, rotarod test, beam test, hot plate test and T-maze tests. Mice were 
housed in groups of three to four in clear plastic cages maintained in a room on a 12 hr 
light/dark schedule with food and water provided ad libitum, unless specified otherwise. 
All experiments were performed in the light phase of the circadian cycle between 10:00 
A.M. and 4:00 P.M. All behavioral testing procedures were approved by the Animal 
Care and Use Committee of Kyoto University, Kyoto, Japan. 
 27 
Grip strength and wire-hanging tests  
Neuromuscular strength was examined by the grip strength and wire-hanging tests. A 
grip strength meter (O’Hara & Co., Tokyo) was used to assess forelimb grip strength. 
Mice were lifted and held by their tail so that their forepaws could grasp a wire grid.  
The mice were then gently pulled backward by the tail with their posture parallel to the 
surface of the table until they released the grid.  The peak force applied by mouse 
forelimbs was recorded in Newtons (N). Each mouse was tested three times and the 
greatest value measured was used for the statistical analysis. In the wire-hanging test, 
mice were placed on a wire mesh that was then inverted and waved gently, so that the 
subject gripped the wire. Latency to fall was recorded, with a 60 sec cut-off time. 
Rotarod test, beam test and hot plate test 
Motor coordination and balance were assessed with a rotarod test and a beam test. We 
performed the rotarod test using an accelerating rotarod (UGO Basile Accelerating 
Rotarod, Italy) by placing a mouse on a rotating drum (3 cm in diameter) and measuring 
the time each animal was able to maintain its balance on the rod as latency time to fall 
(seconds). The speed of the rotarod was accelerated from 4 to 40 rpm over a 5-min 
period. A beam test was performed to measure the ability of mice to traverse a narrow 
beam to reach a dark box29. The beam, with a rough painted surface, consisted of iron 
(100 cm long; 2.8 cm in diameter) placed horizontally 50 cm above the bench surface. 
One session of five trials was performed using the beam. Mice were allowed up to 60 
sec to traverse each beam. The number of sideslips was recorded for each trial by the 
Image OF program. The hot plate test was used to evaluate nociception or sensitivity to 
a painful stimulus. Mice were placed on a hot plate at 55.0 ± 0.3 ˚C (Columbus 
Instruments, Columbus, Ohio), and latency to the first hind-paw response was recorded. 
The hind-paw response was either a foot shake or a paw lick. 
T-maze forced alternation task 
The forced alternation task was conducted using an automatic T-maze that we devised30 
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(O’Hara & Co., Tokyo, Japan). It was constructed of white plastics runways with walls 
25-cm high. The maze was partitioned off into 6 areas by sliding doors that can be 
opened downward. The details of protocols were described previously30. After the 
adaptation session, mice were subjected to a forced alternation protocol for 7 days (one 
session consisting of 10 trials per day; cut-off time, 50 min). Data acquisition, control of 
sliding doors, and data analysis were performed by Image TM software (see 'Image 
analysis'). 
T-maze Left-right discrimination task 
The left-right discrimination task was conducted using an automatic T-maze and 
deprivation before the trials as mentioned above and previously30. On the day after the 
adaptation session, mice were subjected to a left-right discrimination task for 20 days 
(one session consisting of 10 trials, 2 sessions per day; cut-off time, 50 min). The mouse 
was able to freely choose either the right or left arm of the T (A1 and A2). The correct 
arm was assigned to each mouse randomly. If it chose the correct arm, the mouse 
received a reward at the end of the arm. Choosing the incorrect arm resulted in no 
reward and confinement to the arm for 10 sec. After the mouse consumed the pellet or 
the mouse stayed more than 10 sec without consuming the pellet, the door that separated 
the arm (A1 or A2) and connecting passage-way (P1 or P2) was opened and the mouse 
could return to the starting compartment (S1), via the connecting passage-way. On the 
11th day, the correct arm was changed for reversal learning. A variety of fixed 
extra-maze clues surrounded the apparatus. 
Image analysis 
The applications used for the behavioral studies were based on the public domain NIH 
Image program (developed at the U.S. National Institutes of Health and available on the 
Internet at http://rsb.info.nih.gov/nih-image/) and ImageJ program 
http://rsb.info.nih.gov/ij/, which were modified for each test by Miyakawa (available 




Total brain RNA was isolated from snap-frozen brains (at least three mice per genotype, 
at P5) using Trizol (GIBCO-BRL) according to the manufacturer’s protocol. For 
real-time PCR, first strand cDNA was synthesized from total RNA using random 
primers and SuperScriptIII reverse transcriptase (Invitrogen). Quantitative real-time 
PCR was carried out using the ABI Prism 7700 Sequence Detection System and SYBR 
Green Master Mix following the manufacturer’s directions (Applied Biosystems). The 
results were standardized for comparison by measuring levels of β-actin mRNA in each 
sample. Values are expressed as mean ± s.e.m. 
Mouse-specific primers used for real-time PCR were as follows; 
NRG1-typeI, 5’ primer: CTGTGTCTGCCTGGAA 
NRG1-typeI, 3’ primer: CAGCCGTTGGATCCAGA 
NRG1-typeIII, 5’ primer: GCTCTACCAGAAGAGGGTA 
NRG1-typeIII, 3’ primer: GATTCACCAGTTGCACA 
BACE1, 5’ primer: ACCATCCTTCCTCAGCAA 
BACE1, 3’ primer: GGGAATGTTGTAGCCACA 
β-actin, 5’ primer: CTGACTGACTACCTCATGAAGATCCT 
β-actin, 3’ primer: CTTAATGTCACGCACGATTTCC 
 
Statistical analysis 
Data are presented as mean ± s.e.m. Statistical analyses (Student’s two-tailed t-test, 
One-way ANOVA, repeated measures ANOVA) were performed using the STATVIEW 
Software package (SAS institute). 
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Expression of NRDc mRNA (nrd1) in the nervous system. 
a, Images of in situ hybridization of nrd1 and mbp in mouse brain, downloaded from the Allen Brain 
Atlas available from: http://www.brain-map.org.
Note that almost no signal in the corpus callosum is detected for nrd1, while mbp mRNA is strongly 
expressed in the region. 
b, Images of in situ hybridization of nrd1 in mouse spinal cord at the level of C3. Nrd1 expression is 
detected in the gray matter in spinal cord and dorsal root ganglia.
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Supplementary Figure 2
Targeted disruption of the Nrd1 gene.
a, Structure of a part of nrd1, a gene that encodes NRDc (top), the targeting vector (middle), 
and the mutated allele (bottom).  The targeting vector was designed to replace exon 1.  #1-2; primers 
used for screening of targeted ES cells.  #3-5; primers used for routine genotyping of the mutant mice.
b, PCR genotyping of the NRDc-deficient mice.  Primers #3 and #5 amplify the wild-type allele (674 
bp), while primers #4 and #5 amplify the mutant allele (370 bp).
c, Immunohistochemistry using an anti-NRDc antibody with cerebral cortex sections from control 
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Supplementary Figure 3
H & E stained sections of brain hemisphere of Nrd1–/– mice (right) and wild-type littermates (left) at 
P1, P14, P30. 





















































Correlation between the expression level of NRDc and the level of myelination defect in Nrd1–/– 
mice. 
a, Regional distribution of NRDc in wild-type mouse brain.  
Immunohistochemistry using an anti-NRDc antibody (red) and anti-NF-H antibody (green) with sec-
tions from wild-type mice brain. NRDc is expressed in neurons and dendrites, but not clearly detected 
in glial cells. Note that NRDc is highly expressed in cortical neurons, but neurons in striatum express 
relatively low level of NRDc. Scale bars, 250 μm. 
b, Myelination defect in various regions of Nrd1–/– brain. Immunohistochemistry using an anti-MBP 
antibody (green) and anti-NF-H antibody (red) with sections from Nrd1+/+ and Nrd1–/– mice brain. 
Reduction of MBP expression, the myelination defect, is not very obvious in striatum, compared with 



































































No difference in the number of OPC between Nrd1+/+ and Nrd1–/– brains. 
a, Immunohistochemistry using anti-Olig2 antibody in Nrd1+/+ and Nrd1–/– brains at E18.5 and P5. 
Scale bar; 250 μm. 
b, Quantitative analysis of Olig2-positive cells demonstrated that there is no difference in the number of 
Olig2-positive cells between Nrd1+/+ and Nrd1–/– brains at E18.5 and P5. 
Olig2-positive cells were counted at the same levels (20 non-overlapping fields / n = 2 per genotype for 
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Supplementary Figure 6
Delay in the initiation of myelination and hypomyelination in Nrd1–/– mice. 
a, Electron micrographs of transverse sections at the corpus callosum from Nrd1–/– mice (right) and 
Nrd1+/+ littermates (left) at P30 (upper), P120 (middle) and P365 (bottom). Scale bar, 2 μm. 
b, Scatter plots of myelin thickness, expressed as g-ratios, against axon diameters at P30, P120 and 
P365 in Nrd1–/– (black) and wild-type (red) corpus callosum (n = 2 in each genotype for each age). 
No fewer than 500 myelinated fibers from each group were analyzed. 



















































































Behavioral tests (Supplement for Figure 7).
a,  Wire-hang test showed no significant difference between Nrd1+/+ and Nrd1–/– mice.
b, Hot plate test showed no significant difference in nociception or sensitivity to a paiful stimulus 
between Nrd1+/+ and Nrd1–/– mice.
c,  Latency to complete session in the T-maze L-R discrimination task. Nrd1–/– mice took much longer 
to finish a session than did Nrd1+/+ mice, most likely due to their slow walking. Age-matched litter-
mates, n = 12; Nrd1+/+, n = 6; Nrd1–/–. 






































































Bace1 and Nrg1 mRNA expression in brain.
Bace1, Nrg1-typeI and Nrg1-typeIII mRNA levels in Nrd1+/+ and Nrd1–/– brains 
(P5; n = 3 for each genotype) were analyzed by real-time PCR. 
Expression level of each mRNA was standardized by that of β-actin, and the ratio 
was arbitrarily set at 1 in Nrd1+/+.
There were no differences in the mRNA levels between Nrd1+/+ and Nrd1–/– 
brains. Data represent mean ± s.e.m.
n.s. n.s. n.s.
Supplementary Figure 9
Full-length blots for Figure 1a 
Full-length blots for Figure 2g
Full-length blots for Figure 5f
Full-length blots for Figure 6e
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